We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




First Of Its Kind Wearable Sticker Accurately Monitors and Detects Changes in Breathing

By HospiMedica International staff writers
Posted on 19 Dec 2024

Chronic respiratory diseases, such as asthma, sleep apnea, and chronic obstructive pulmonary disease, impact over 435 million people worldwide. More...

In many of these conditions, changes in breathing rate can be the earliest sign of patient deterioration, including in diseases like sepsis and COVID-19. At present, hospitals rely on nurses to manually count a patient's breaths per minute, which can lead to delays in detecting changes and responding to treatment. While there are chest band and facemask systems designed to monitor respiration continuously, these can be invasive and uncomfortable for long-term use. This has prompted efforts to develop non-invasive methods for accurately and efficiently measuring respiratory rates. Researchers have now introduced a wearable 'sticker' that can track and detect changes in breathing, even without direct skin contact. This innovative device, considered the first of its kind, is expected to be used in both healthcare settings and at home to provide an early alert for declining health, potentially saving lives.

A study led by Nottingham Trent University (Nottingham, UK) resulted in the creation of the Pneumorator, a device capable of monitoring respiratory rate over extended periods. The device uses a series of functional layers that detect the frequency variation caused by breathing, accurately identifying subtle changes related to chest expansion and lung composition. Published in the journal Sensors, the study showed that the device was able to continuously measure the respiratory rate of volunteers with an accuracy of two breaths per minute. The team emphasized that the device is cost-effective and can be mass-produced. It interfaces wirelessly with a smartphone or tablet app, providing healthcare teams with data for early warnings. The device will now undergo further validation in a clinical trial aimed at achieving regulatory approval.

“This is a groundbreaking wearable innovation meticulously developed to provide crucial support for patients and healthcare professionals,” said Dr Yang Wei, an expert in electronic textiles and electronic engineering at Nottingham Trent University’s Medical Technologies Innovation Facility. “The ability to continuously measure respiration in this way gives us the potential to enable faster, more effective treatment, significantly enhancing patient outcomes and operational efficiency within the health service.”


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.